Cecka J M, Terasaki P I
UCLA Tissue Typing Laboratory.
Clin Transpl. 1990:1-10.
Based upon data reported to the UNOS Scientific Renal Transplant Registry between October 1987 and October 1990: 1. One-year graft survival rates were 78% for 14,203 recipients of first cadaver donor transplants, 70% for 2180 recipients of second cadaver transplants, and 59% for 487 recipients of third or fourth transplants. First transplants from living donors had 90% 1-year graft survival. 2. One-year graft survival was 75% for 2,273 Black recipients of first cadaver transplants and ranged between 79-80% for recipients of other races (p less than 0.001). 3. Broadly sensitized (50% peak PRA) first cadaver transplant recipients had 77% 1-year graft survival versus 79% for nonsensitized or narrowly sensitized recipients. Cadaver retransplant recipients with greater than 10% peak PRA had 65% 1-year graft survival while those transplanted with no antibody had 78% (p less than 0.001). Survival of nonsensitized retransplanted patients was not significantly less than first transplant recipients. 4. Graft survival was 78% at 1 year for both male and female recipients of first cadaver donor transplants. Retransplanted females had significantly higher 1-year graft survival at 70% than males at 67% (p less than 0.01). Male donor kidneys had significantly higher survival rates than female donor kidneys in both first and retransplanted patients. One-year graft survival was 79% and 70% with male donors and 75% and 65% with female donors in first and retransplants, respectively (p less than 0.01). 5. Pediatric recipients (under 16) and older recipients (over 60) of first cadaver transplants had 73% 1-year graft survival compared to 78-79% for those aged 16-60. 6. Among recipients of first cadaver transplants, 1-year graft survival rates varied over a 20% range with the age of the donor. Excluding pediatric and older patients, the best survival rates (81%) were obtained with kidneys from donors aged 16-45. Kidneys from younger and older donors yielded progressively poorer results. The lowest survival was with 181 donors aged 1-5 (60%) and 145 donors over 60 (69%). 7. One-year graft survival was 85% for 274 recipients of 0 HLA-A,B,DR-mismatched first cadaver transplants and 74% for 717 recipients of transplants mismatched for 6 HLA-A,B,DR antigens. Graft survival progressively declined with increasing histoincompatibility. 8. One-year graft survival decreased by 20% if the kidney failed to produce urine in the first hour, from 80-60% in first transplant recipients and from 72-50% in retransplanted patients.(ABSTRACT TRUNCATED AT 400 WORDS)
根据1987年10月至1990年10月期间向器官共享联合网络(UNOS)科学肾脏移植登记处报告的数据:1. 14203例首次尸体供体移植受者的1年移植肾存活率为78%,2180例第二次尸体移植受者的为70%,487例第三次或第四次移植受者的为59%。活体供体的首次移植1年移植肾存活率为90%。2. 2273例首次尸体移植的黑人受者1年移植肾存活率为75%,其他种族受者的存活率在79%至80%之间(p<0.001)。3. 高度致敏(峰值PRA为50%)的首次尸体移植受者1年移植肾存活率为77%,未致敏或轻度致敏受者为79%。峰值PRA大于10%的尸体再次移植受者1年移植肾存活率为65%,而未检测到抗体的移植受者为78%(p<0.001)。未致敏再次移植患者的存活率与首次移植受者相比无显著降低。4. 首次尸体供体移植的男性和女性受者1年移植肾存活率均为78%。再次移植的女性1年移植肾存活率显著高于男性,分别为70%和67%(p<0.01)。在首次移植和再次移植患者中,男性供体肾的存活率均显著高于女性供体肾。首次移植和再次移植中,男性供体的1年移植肾存活率分别为79%和70%,女性供体分别为75%和65%(p<0.01)。5. 首次尸体移植的儿科受者(16岁以下)和老年受者(60岁以上)1年移植肾存活率为73%,而16至60岁的受者为78%至79%。6. 在首次尸体移植受者中,1年移植肾存活率随供体年龄变化幅度达20%。排除儿科和老年患者,16至45岁供体的肾脏存活率最高(81%)。较年轻和较年长供体的肾脏结果逐渐变差。存活率最低的是181例1至5岁供体(60%)和145例60岁以上供体(69%)。7. 274例0个HLA - A、B、DR错配的首次尸体移植受者1年移植肾存活率为85%,717例6个HLA - A、B、DR抗原错配的移植受者为74%。移植肾存活率随组织相容性增加而逐渐下降。8. 如果肾脏在第一小时内无尿,首次移植受者的1年移植肾存活率下降20%,从80%降至60%,再次移植患者从72%降至50%。(摘要截断于400字)